Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Huet

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The EMBO Journal|September 2, 1996
Localization of yeast RNA polymerase I core subunits by immunoelectron microscopyC Klinger, J Huet, D Song, et al.
Journal of Lipid Mediators and Cell Signalling|January 1, 1997
Design and modeling of new platelet-activating factor antagonists. 3. Relative importance of hydrophobicity and electronic distribution in piperazinic seriesF Heymans, G Dive, A Lamouri, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|July 17, 1998
[Diagnostic value of Gram staining of peri-catheter skin and the connection in the prediction of intravascular-catheter-related bacteremia]M León, M García, M A Herranz, et al.
The EMBO Journal|December 16, 1985
A general upstream binding factor for genes of the yeast translational apparatusJ Huet, P Cottrelle, M Cool, et al.
Pediatrics|June 3, 2004
Insurance status and vaccination coverage among US preschool childrenJeanne M Santoli, Natalie J Huet, Philip J Smith, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1985
Lower body positive pressure vs. dopamine during PEEP in humansD M Payen, P A Carli, C J Brun-Buisson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1986
Isolation of structural genes for yeast RNA polymerases by immunological screeningM Riva, S Memet, J Y Micouin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques)M Riggi, P Ruffie, S Voisin, et al.
European Journal of Medicinal Chemistry|December 12, 2001
Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A(2) inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazinesC Binisti, L Assogba, E Touboul, et al.
Journal of Medicinal Chemistry|June 8, 2000
Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replicationN Serradji, O Bensaid, M Martin, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The EMBO Journal|September 2, 1996
Localization of yeast RNA polymerase I core subunits by immunoelectron microscopyC Klinger, J Huet, D Song, et al.
Journal of Lipid Mediators and Cell Signalling|January 1, 1997
Design and modeling of new platelet-activating factor antagonists. 3. Relative importance of hydrophobicity and electronic distribution in piperazinic seriesF Heymans, G Dive, A Lamouri, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|July 17, 1998
[Diagnostic value of Gram staining of peri-catheter skin and the connection in the prediction of intravascular-catheter-related bacteremia]M León, M García, M A Herranz, et al.
The EMBO Journal|December 16, 1985
A general upstream binding factor for genes of the yeast translational apparatusJ Huet, P Cottrelle, M Cool, et al.
Pediatrics|June 3, 2004
Insurance status and vaccination coverage among US preschool childrenJeanne M Santoli, Natalie J Huet, Philip J Smith, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1985
Lower body positive pressure vs. dopamine during PEEP in humansD M Payen, P A Carli, C J Brun-Buisson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1986
Isolation of structural genes for yeast RNA polymerases by immunological screeningM Riva, S Memet, J Y Micouin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques)M Riggi, P Ruffie, S Voisin, et al.
European Journal of Medicinal Chemistry|December 12, 2001
Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A(2) inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazinesC Binisti, L Assogba, E Touboul, et al.
Journal of Medicinal Chemistry|June 8, 2000
Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replicationN Serradji, O Bensaid, M Martin, et al.
Pageof 8